Ingenix: Seed+Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug developmentOct 4, 2026RoundOSIngenixCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeed · AIBiotechEnterprise softwareEuropeSeed